Remove 2003 Remove Drugs Remove Pharma Companies Remove Pharmaceuticals
article thumbnail

Where is the drug discovery expertise happening in the UK?

Drug Discovery World

The United Kingdom has established itself as a hub for drug discovery expertise worldwide. There is a range of reasons why this area has become focal point for drug discovery, one of which is the fact that it encompasses the University of Oxford and the University of Cambridge, two of the oldest and most prestigious universities in the world.

Drugs 189
article thumbnail

AIM ImmunoTech Announces Availability of the ME/CFS Clinical Trial of its Drug Ampligen for Enrollment to COVID-19 ‘Long Haulers’Institutional Review Board Authorizes Public Notification for Potential Enrollment of Subjects

The Pharma Data

Eligible patients enrolled in the trial receive treatment with AIM’s flagship pipeline drug Ampligen. It is approved in Argentina as the world’s first therapy for severe Chronic Fatigue Syndrome and is the only late-stage drug in the U.S. Ampligen is AIM’s TLR3 agonist immune-system modulator. development pipeline for ME/CFS.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Decentralised identities: Blockchain based informed consent

Drug Discovery World

An obvious opportunity could be to demonstrate the interoperability of BlockSent with EDC systems that are commonly used in clinical trials by pharma companies and to combine BlockSent with a blockchain network offering a smart contract 15 capability. BMJ 2003; 327: 484-487. Drug Information Journal 2014; 38: 239-251.

article thumbnail

Decentralised identities: Blockchain based informed consent

Drug Discovery World

An obvious opportunity could be to demonstrate the interoperability of BlockSent with EDC systems that are commonly used in clinical trials by pharma companies and to combine BlockSent with a blockchain network offering a smart contract 15 capability. BMJ 2003; 327: 484-487. Drug Information Journal 2014; 38: 239-251.